ATC code N07

ATC code N07 Other nervous system drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup N07 is part of the anatomical group N Nervous system.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN07.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

N07A Parasympathomimetics

N07AA Anticholinesterases

N07AA01 Neostigmine

N07AA02 Pyridostigmine

N07AA03 Distigmine

N07AA30 Ambenonium

N07AA51 Neostigmine, combinations

N07AB Choline esters

N07AB01 Carbachol

N07AB02 Bethanechol

N07AX Other parasympathomimetics

N07AX01 Pilocarpine

N07AX02 Choline alfoscerate

N07AX03 Cevimeline

N07B Drugs used in addictive disorders

N07BC51 Buprenorphine, combinations

N07C Vertigo preparations

N07CA Antivertigo preparations

N07CA01 Betahistine

N07CA02 Cinnarizine

N07CA03 Flunarizine

N07CA04 Acetylleucine

N07CA52 Cinnarizine, combinations

N07X Other nervous system drugs

N07XA Gangliosides and ganglioside derivatives

Empty group

N07XX Other nervous system drugs

N07XX01 Tirilazad

N07XX02 Riluzole

N07XX03 Xaliproden

N07XX04 Sodium oxybate

N07XX05 Amifampridine

N07XX06 Tetrabenazine

N07XX07 Fampridine

N07XX08 Tafamidis

N07XX10 Laquinimod

N07XX11 Pitolisant

N07XX12 Patisiran

N07XX13 Valbenazine

N07XX14 Edaravone

N07XX15 Inotersen

N07XX16 Deutetrabenazine

N07XX17 Arimoclomol

N07XX18 Vutrisiran

N07XX19 Sodium phenylbutyrate and ursodoxicoltaurine

N07XX21 Eplontersen

N07XX22 Tofersen

N07XX23 Troriluzole

N07XX24 Trofinetide

N07XX25 Omaveloxolone

N07XX59 Dextromethorphan, combinations

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code N07". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QN07". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code N07". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QN07". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

v t e Treatment of drug dependence (N07B)
Nicotine dependence	Bupropion^# Cytisine Lobeline Mecamylamine Varenicline AATooltip Adrenergic agonist (Clonidine)
Alcohol dependence	AD inhibitor Disulfiram Acamprosate Calcium carbimide Hydrogen cyanamide General anesthetics Nitrous oxide Opioid antagonists Naltrexone Nalmefene Topiramate AATooltip Adrenergic agonist (Clonidine) Baclofen Phenibut
Opioid dependence	AATooltip Adrenergic agonist (Clonidine Lofexidine) Ibogaine Opioids Buprenorphine (+naloxone) Levacetylmethadol Methadone Dihydrocodeine Dihydroetorphine Hydromorphone (extended-release) Morphine (extended-release) Opioid antagonists (Naltrexone Nalmefene)
Benzodiazepine dependence	AATooltip Adrenergic agonist (Clonidine) Benzodiazepines (Diazepam Lorazepam Chlordiazepoxide Oxazepam) Barbiturates (Phenobarbital)

v t e Other nervous system drugs (N07X)
Stroke	Tirilazad
ALS	Mecasermin rinfabate^† Riluzole Xaliproden
Other	Amifampridine Arimoclomol Edaravone Eplontersen Fampridine Hydroxybutyric acid Inotersen Laquinimod Patisiran Pitolisant Sodium oxybate Sodium phenylbutyrate/ursodoxicoltaurine Tafamidis Tofersen Troriluzole Vutrisiran hyperkinesis Deutetrabenazine Tetrabenazine Valbenazine
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

ATC code N: Nervous system
N01 Anesthetics N02 Analgesics N03 Antiepileptics N04 Anti-parkinson drugs N05 Psycholeptics N06 Psychoanaleptics N07 Other nervous system drugs
ATCvet only
QN51 Products for animal euthanasia
Other ATC codes
A B C D G H QI J L M N P R S V